BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile


Bristol-Myers Squibb World Wide Medicines Group 

Lawrenceville  New Jersey    U.S.A.
Phone: 609-252-4938 Fax: 609-252-6703


Bristol-Myers Squibb is a leading global diversified health and personal care products company with annual sales in excess of $20 billion (1999). Headquartered in New York City, the company employs 54,000 people worldwide. More than 70 percent of company sales are in pharmaceuticals and consumer medicines. Other core businesses include beauty care, nutritional products and medical devices. Nearly 40 percent of company sales come from outside the United States.

Drawing on substantial investments in research and development and on many licensing and alliance agreements, Bristol-Myers Squibb has become a global leader in several key therapeutic areas. The company is the number one provider of cancer medicines worldwide, and also develops important treatments for Type 2 diabetes, high cholesterol, hypertension, HIV/AIDS and other infectious diseases, depression, anxiety and pain. Expenditures on research and development surpassed $1.8 billion in 1999, and continue to grow at a double-digit rate. More than 4,500 people are involved in R&D in the company’s Pharmaceutical Research Institute facilities in the U.S. and abroad.

Reflecting the company’s broad commitment to extending and enhancing human life, Bristol-Myers Squibb supports a number of philanthropic projects, including “Secure the Future”, a $100 million initiative to fight HIV/AIDS among women and children in southern Africa. In addition, the company provided $100 million in cash and product donations in 1999 to help promote research and education, as well as strengthen communities and rebuild societies after natural disasters.

 Key Statistics

Ownership: Public

Web Site: Bristol-Myers Squibb World Wide Medicines Group
Employees: 53,600
Symbol: BMY

Big Pharma

 Company News
Bristol-Myers Squibb Company (BMY) Invites Yahoo!'s Global Audience To Shine A Light On HIV/AIDS Epidemic On World AIDS Day10/19/2005 5:12:20 PM
Medarex, Inc. (MEDX) To Host Conference Call Today To Discuss Bristol-Myers Squibb Company (BMY) Development And Commercialization Collaboration For MDX-01010/19/2005 5:12:06 PM
Bristol-Myers Squibb Foundation And China Foundation For Hepatitis Prevention And Control Collaborate To Fight One Of China's Most Pressing Health Problems10/19/2005 5:12:02 PM
Bristol-Myers Squibb Company (BMY) Use Of Investigational Agent Entecavir Demonstrated Statistically Significant Improvement In Liver Histology And Viral Suppression Compared To Lamivudine In Chronically Infected Hepatitis B E-Antigen (HBeAg) Positive Patients10/19/2005 5:12:00 PM
Bristol-Myers Squibb Company (BMY) Appoints Dr. Elliott Sigal Chief Scientific Officer And President Of The Pharmaceutical Research Institute 10/19/2005 5:12:00 PM
Bristol-Myers Squibb Company (BMY) Release: Pioneering Researchers Receive Distinguished Achievement Awards In Biomedicine10/19/2005 5:11:50 PM
Bristol-Myers Squibb Company (BMY) Release: International Research Scientists Join NYC High School Students In "Science's Next Generation" Program10/19/2005 5:11:50 PM